An observational study in Depressive Disorder, sponsored by Shanghai Mental Health Center. Active, not recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2021-10-27.
Sponsored by Shanghai Mental Health Center · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Depressive Disorder with a site in China — 21 open to participants now, 23 under way, 2 of them phase 3. Depressive Disorder · China.
Among the 54 studies in Depressive Disorder with a site in China, this one has the largest planned enrollment of the 12 observational ones that give a count, is one of 3 that started in 2021, is one of 12 observational ones, reaches primary completion later than 13 of the 22 other live ones, and was the 25th registered.
857 studies on the registry are indexed under Depressive Disorder; 160 are open to participants now.
Browse Depressive Disorder studies →21 of the 54 studies in Depressive Disorder with a site in China are open now. Recruiting first, the newest first:
Second Affiliated Hospital, Zhejiang University, School of Medicine · Sites in China
Ages 12–55 · Healthy volunteers
Eli Lilly and Company · Sites in China, United States, Australia and 12 more countries
Ages 18–75
Guo Wenbin · Sites in China
Ages 18–45
Peking University · Sites in China
Ages 18–65
Eli Lilly and Company · Sites in China, United States, Australia and 12 more countries
Ages 18–75
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 116 Depressive Disorder studies recruiting now, 44 (38%) set no upper age limit and 66 (57%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 3 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80,000 is above the median of 174 across 140 observational studies indexed under Depressive Disorder.
Median enrollment 120 across the 42 interventional studies, 180 across the 12 observational. Of the 18 that completed or were terminated, 1 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 54 have an industry lead sponsor. The 10 most frequent:
Shanghai Mental Health Center is the lead sponsor of 277 studies on the registry; 95 are open to participants now.
Shanghai Mental Health Center has 7 studies filed under Depressive Disorder — fewer than ten, so there is no comparison to draw.
5 of the studies in Depressive Disorder with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05095662Shanghai Mental Health CenterEstablish a Specific Cohort Database for Depressive Disorders | 2026-12-31 |
| NCT07290153Fudan UniversityPsychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBC | 2027-06-30 |
| NCT07813169Guo WenbinStudy on iTBS Regulating the Reward Circuit Function to Improve Anhedonia in Depression | 2027-07-03 |
| NCT07639476Beijing HuiLongGuan HospitalStudy on Mental Health Promoting Effects of Natural Psychotherapy for Adolescents | 2027-07-31 |
| NCT07252427Fang TangGut Microbiota in IBD With Comorbid Depressive Disorder | 2027-11-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 54 studies in Depressive Disorder with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Depression is characterized by high prevalence, high recurrence rate, high disability rate, high suicide rate, and heavy disease burden. However, the diagnosis, treatment, and prognosis of depression are difficult to meet the clinical needs at present. This study plans to integrate a large sample of hospital clinical data, laboratory examination data, brain imaging, and electrophysiological data, as well as audio-visual data, to establish a database for depressive disorder, and long-term follow-up to form a specific disease cohort. This study will provide a scientific basis for exploring biomarkers related to objective diagnosis and treatment of depression.
Together with three tertiary hospitals in Shanghai, Shanghai Tenth People's Hospital, Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine, and Zhongshan Hospital affiliated to Fudan University, Shanghai Mental Health Center will take a lead to establish a big database focused on depressive disorders. Expert consensus will be used to determine the standard for the dataset. Real-world data will be include. To establish a depressive disorders-specific database with multiple functions, such as data insight, data retrieval, cohort project establishment, follow-up, and statistical analysis.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Construct the structured data set for depression by integrating a large sample of outpatient and inpatient clinical data, blood tests, psychological tests, and brain imaging data.
Have 80000 patients been included.
Time frame: 3 years
Recruitment of 300 patients who was diagnosed as depressive disorders.
In order to: collect demographic and sociological information., clinical data, social function, cognitive function, and blood index test. Collection of Audio-Visual, as well as brain imaging or electrophysiology if patients agreed to participate in these tests.
Time frame: Baseline, and 1,2,3,4,5 years follow-up point
Plan to share: No
Started Jun 2021 (actual). Primary completion is estimated for Dec 2026, 66 months after the start.
Of 54 non-industry observational studies under Depressive Disorder, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 104. This study's planned 66 months is above that.
Counting every sponsor, half of 57 studies reached it within 38 months; a quarter within 21 and three quarters within 104.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Mental Health Center →